on 11 Jan 2022
Last Applicant/ Owned by
CH-4051 Basel
CH
Serial Number
79285070 filed on 25th Mar 2020
Registration Number
6610085 registered on 11th Jan 2022
Correspondent Address
MONICA RIVA TALLEY
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respi Read More
Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; medical and veterinary preparations, namely, recombinant or chemically synthesized and optimized proteins; preparations for destroying vermin; fungicides, herbicides; biotechnological preparations, namely, recombinant or chemically synthesized and optimized proteins for medical use; enzymes for medical use; enzymes for veterinary use; biological and chemical reagents for medical or veterinary use; amino acids for medical use; amino acids for veterinary use; peptides for medical or veterinary use, namely, for the treatment of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; proteins for medical or veterinary use, namely, recombinant or chemically synthesized and optimized proteins for detection and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, nutritional diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; pharmaceutical preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical compositions and preparations for cancer prevention and treatment; pharmaceutical preparations for treatment of autoimmune and inflammatory diseases; pharmaceutical preparations for treatment of skin diseases; pharmaceutical preparations for treatment of neurodegenerative, metabolic and ophthalmological diseases
Scientific and technological services, namely, scientific research, scientific analysis, and scientific testing in the field of biotechnology and new product research and design services relating thereto; research and development in the field of biotechnology; consulting services in the field of biotechnology; scientific research services in the field of proteins, peptides and antibodies, and scientific advice relating thereto; scientific research services for medical purposes in the field of cancer and autoimmune diseases and scientific advice relating thereto
No 79285070
No Service Mark
No 4697.0010000
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
11th Jan 2022 | REGISTERED-PRINCIPAL REGISTER |
04th Nov 2021 | NOTIFICATION PROCESSED BY IB |
03rd Nov 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
26th Oct 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
26th Oct 2021 | PUBLISHED FOR OPPOSITION |
13th Oct 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
13th Oct 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
06th Oct 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
06th Oct 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
06th Oct 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |